dacarbazine,doxorubicin,nivolumab,vinblastine
bms
['nivo', 'cml']
moskowitz presenting on behalf of et al nivo-avd older pts - med 66y (38% &gt; 70y) largely a fitter group (chemo fit) 97% crr 2y pfs 86%, 2y os 96% no unexpected safety issues excellent results in an older gp. #17icml #icml23 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.